Fundraising FoxKinomica
Macclesfield, GB · 2 known investors
Find your way into Kinomica
Sign up to see every warm intro you have to Kinomica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kinomica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kinomica develops mass spectrometry-based diagnostic tests that measure protein activity to predict patient responses to multiple drugs. The company aims to advance precision medicine by enabling companion diagnostics that help match patients to appropriate therapeutic options.
Founders & leadership
Investors · 2
How we know: the Companies House PSC register · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2021
Pioneer Group
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- KINOMICA LIMITED
- Company number
- 10405843
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 1 Oct 2016
- Registered office
- Biohub Alderley Park, Alderley Edge, Macclesfield, Cheshire, SK10 4TG
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- PRONOSTICS LTD. (2016–2017)
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 22 Dec 2025 · next due 5 Jan 2027
Current officers · 4
- Pedro Rodriguez Cutillas — director, appointed 1 Oct 2016
- Michele Pedrocchi — director, appointed 18 Jan 2024
- Rebecca Thirza Todd — director, appointed 11 Dec 2020
- Mercia Fund Management (nominees) Limited — corporate director, appointed 25 Mar 2026
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Kinomica do?
- Kinomica develops mass spectrometry-based diagnostic tests that measure protein activity to predict patient responses to multiple drugs. The company aims to advance precision medicine by enabling companion diagnostics that help match patients to appropriate therapeutic options.
- Who are Kinomica's investors?
- Kinomica's investors include Longwall Venture Partners LLP.
- Where is Kinomica headquartered?
- Kinomica is headquartered in Macclesfield, GB.